Dr. Peter Ewald, MD

NPI: 1144299801
Total Payments
$6,681
2020 Payments
$228.79
Companies
31
Transactions
57

Payment Breakdown by Category

Food & Beverage$6,681 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $6,681 57 100.0%

Top Paying Companies

Company Total Records Latest Year
Shire North American Group Inc $535.08 4 $0 (2019)
Exelixis Inc. $518.51 4 $0 (2019)
Gilead Sciences, Inc. $461.77 4 $0 (2019)
AstraZeneca Pharmaceuticals LP $407.14 4 $0 (2019)
AbbVie Inc. $379.97 3 $0 (2020)
Otsuka America Pharmaceutical, Inc. $371.84 3 $0 (2019)
Boehringer Ingelheim Pharmaceuticals, Inc. $362.27 3 $0 (2018)
Merck Sharp & Dohme Corporation $347.92 3 $0 (2019)
Novartis Pharmaceuticals Corporation $343.32 3 $0 (2019)
PORTOLA PHARMACEUTICALS, INC. $250.91 2 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2020 $228.79 2 AbbVie Inc. ($121.09)
2019 $2,691 22 Shire North American Group Inc ($401.86)
2018 $2,504 22 Merck Sharp & Dohme Corporation ($248.20)
2017 $1,258 11 Boehringer Ingelheim Pharmaceuticals, Inc. ($238.49)

All Payment Transactions

57 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
02/19/2020 Takeda Pharmaceuticals U.S.A., Inc. ADVATE (Biological) Food and Beverage In-kind items and services $107.70 General
Category: HEMATOLOGY
01/23/2020 AbbVie Inc. Food and Beverage In-kind items and services $121.09 General
11/21/2019 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $116.00 General
Category: Cardiovascular and Metabolism
11/19/2019 Merck Sharp & Dohme Corporation DIFICID (Drug), ZINPLAVA Food and Beverage In-kind items and services $99.72 General
Category: INFECTIOUS DISEASE
11/13/2019 Amarin Pharma Inc. Vascepa (Drug) Food and Beverage In-kind items and services $128.50 General
Category: Hypertriglyceridemia
11/06/2019 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $112.57 General
Category: Cardiovascular and Metabolism
10/15/2019 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $114.90 General
Category: Cardiovascular & Metabolism
10/09/2019 Exelixis Inc. Cabometyx (Drug) Food and Beverage In-kind items and services $135.00 General
Category: Oncology
09/10/2019 Shire North American Group Inc ADVATE (Biological) Food and Beverage In-kind items and services $138.31 General
Category: HEMATOLOGY
08/27/2019 Astellas Pharma US Inc XOSPATA (Drug) Food and Beverage In-kind items and services $125.00 General
Category: ONCOLOGY
08/22/2019 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Food and Beverage In-kind items and services $110.93 General
Category: RESPIRATORY
08/13/2019 Dynavax Technologies Corporation Heplisav-B (Drug) Food and Beverage In-kind items and services $117.16 General
Category: Hepatitis B Vaccine
07/24/2019 Gilead Sciences, Inc. Truvada (Drug) Food and Beverage In-kind items and services $125.00 General
Category: HIV
07/17/2019 Shire North American Group Inc ADVATE (Biological), ADYNOVATE, FEIBA Food and Beverage In-kind items and services $121.01 General
Category: HEMATOLOGY
07/11/2019 Dynavax Technologies Corporation Heplisav-B (Drug) Food and Beverage In-kind items and services $124.99 General
Category: Hepatitis B Vaccine
04/18/2019 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $124.97 General
Category: PSYCHIATRY
04/11/2019 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $113.88 General
03/26/2019 Shire North American Group Inc ADVATE (Biological) Food and Beverage In-kind items and services $142.54 General
Category: HEMATOLOGY
02/28/2019 Relypsa, Inc. Veltassa (Drug) Food and Beverage In-kind items and services $118.80 General
Category: Hyperkalemia
02/26/2019 BioDelivery Sciences International, Inc. BELBUCA (Drug) Food and Beverage In-kind items and services $124.99 General
Category: Addiction Therapy
02/07/2019 Exelixis Inc. Cabometyx (Drug) Food and Beverage In-kind items and services $135.00 General
Category: Oncology
02/07/2019 Exelixis Inc. Cabometyx (Drug) Food and Beverage In-kind items and services $122.64 General
Category: Oncology
01/30/2019 PORTOLA PHARMACEUTICALS, INC. ANDEXXA (Biological) Food and Beverage In-kind items and services $125.99 General
Category: HEMATOLOGY/NEUROLOGY
01/18/2019 AbbVie, Inc. Venclexta (Drug) Food and Beverage In-kind items and services $112.66 General
Category: Virology
12/19/2018 Fresenius Kabi USA, LLC Smoflipid (Drug) Food and Beverage In-kind items and services $100.00 General
Category: Nutrition

About Dr. Peter Ewald, MD

Dr. Peter Ewald, MD is a Pediatrics healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144299801.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Ewald, MD has received a total of $6,681 in payments from pharmaceutical and medical device companies, with $228.79 received in 2020. These payments were reported across 57 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($6,681).

Practice Information

  • Specialty Pediatrics
  • Location San Francisco, CA
  • Active Since 03/15/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • NPI Number 1144299801

Products in Payments

  • ADVATE (Biological) $642.78
  • Cabometyx (Drug) $518.51
  • KEYTRUDA (Biological) $248.20
  • Truvada (Drug) $245.06
  • Heplisav-B (Drug) $242.15
  • JARDIANCE (Drug) $238.49
  • LOKELMA (Drug) $228.57
  • Vemlidy (Drug) $216.71
  • Creon (Drug) $146.22
  • ELIQUIS (Drug) $135.00
  • TECENTRIQ (Biological) $128.63
  • Vascepa (Drug) $128.50
  • ANDEXXA (Biological) $125.99
  • RESTASIS (Drug) $125.19
  • TASIGNA (Drug) $125.00
  • XOSPATA (Drug) $125.00
  • ABILIFY MAINTENA (Drug) $124.99
  • BELBUCA (Drug) $124.99
  • TRELEGY ELLIPTA (Drug) $124.99
  • REXULTI (Drug) $124.97

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in San Francisco